Department of Reproductive Biology CECOS, Hôpital Antoine Béclère, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Clamart, France.
Department of Reproductive Biology CECOS, Hôpital Tenon, Hôpitaux Universitaires Est Parisien, Assistance Publique-Hôpitaux de Paris, Paris, France.
Hum Reprod. 2024 Apr 3;39(4):724-732. doi: 10.1093/humrep/deae027.
Is large for gestational age (LGA) observed in babies born after frozen embryo transfer (FET) associated with either the freezing technique or the endometrial preparation protocol?
Artificial cycles are associated with a higher risk of LGA, with no difference in rate between the two freezing techniques (vitrification versus slow freezing) or embryo stage (cleaved embryo versus blastocyst).
Several studies have compared neonatal outcomes after fresh embryo transfer (ET) and FET and shown that FET is associated with improved neonatal outcomes, including reduced risks of preterm birth, low birthweight, and small for gestational age (SGA), when compared with fresh ET. However, these studies also revealed an increased risk of LGA after FET. The underlying pathophysiology of this increased risk remains unclear; parental infertility, laboratory procedures (including embryo culture conditions and freezing-thawing processes), and endometrial preparation treatments might be involved.
STUDY DESIGN, SIZE, DURATION: A multicentre epidemiological data study was performed through a retrospective analysis of the standardized individual clinical records of the French national register of IVF from 2014 to 2018, including single deliveries resulting from fresh ET or FET that were prospectively collected in fertility centres. Complementary data were collected from the participating fertility centres and included the vitrification media and devices, and the endometrial preparation protocols.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Data were collected from 35 French ART centres, leading to the inclusion of a total of 72 789 fresh ET, 10 602 slow-freezing FET, and 39 062 vitrification FET. Main clinical outcomes were presented according to origin of the transferred embryos (fresh, slow frozen, or vitrified embryos) and endometrial preparations for FET (ovulatory or artificial cycles), comparing five different groups (fresh, slow freezing-ovulatory cycle, slow freezing-artificial cycle, vitrification-ovulatory cycle, and vitrification-artificial cycle). Foetal growth disorders were defined in live-born singletons according to gestational age and sex-specific weight percentile distribution: SGA and LGA if <10th and ≥90th percentiles, respectively. Analyses were performed using linear mixed models with the ART centres as random effect.
Transfers led to, respectively, 19 006, 1798, and 9195 deliveries corresponding to delivery rates per transfer of 26.1%, 17.0%, and 23.5% after fresh ET, slow-freezing FET, and vitrification FET, respectively. FET cycles were performed in either ovulatory cycles (n = 21 704) or artificial cycles (n = 34 237), leading to 5910 and 10 322 pregnancies, respectively, and corresponding to pregnancy rates per transfer of 31.6% and 33.3%. A significantly higher rate of spontaneous miscarriage was observed in artificial cycles when compared with ovulatory cycles (33.3% versus 21.4%, P < 0.001, in slow freezing groups and 31.6% versus 21.8%, P < 0.001 in vitrification groups). Consequently, a lower delivery rate per transfer was observed in artificial cycles compared with ovulatory cycles both in slow freezing and vitrification groups (15.5% versus 18.9%, P < 0.001 and 22.8% versus 24.9%, P < 0.001, respectively). Among a total of 26 585 live-born singletons, 16 413 babies were born from fresh ET, 1644 from slow-freezing FET, and 8528 from vitrification FET. Birthweight was significantly higher in the FET groups than in the fresh ET group, with no difference between the two freezing techniques. Likewise, LGA rates were higher and SGA rates were lower in the FET groups compared with the fresh ET group whatever the method used for embryo freezing. In a multivariable analysis, the risk of LGA following FET was significantly increased in artificial compared with ovulatory cycles. In contrast, the risk of LGA was not associated with either the freezing procedure (vitrification versus slow freezing) or the embryo stage (cleaved embryo versus blastocyst) at freezing. Regarding the vitrification method, the risk of LGA was not associated with either the vitrification medium used or the embryo stage.
LIMITATIONS, REASONS FOR CAUTION: No data were available on maternal context, such as parity, BMI, infertility cause, or maternal comorbidities, in the French national database. In particular, we cannot exclude that the increased risk of LGA observed following FET with artificial cycles may, at least partially, be associated with a confounding effect of some maternal factors. No information about embryo culture and incubation conditions was available. Most of the vitrification techniques were performed using the same device and with two main vitrification media, limiting the validity of a comparison of risk for LGA according to the device or vitrification media used.
Our results seem reassuring, since no potential foetal growth disorders following embryo vitrification in comparison with slow freezing were observed. Even if other factors are involved, the endometrial preparation treatment seems to have the greatest impact on LGA risk following FET. FET during ovulatory cycles could minimize the risk for foetal growth disorders.
STUDY FUNDING/COMPETING INTEREST(S): This work has received funding from the French Biomedicine Agency (Grant number: 19AMP002). None of the authors has any conflict of interest to declare.
N/A.
冷冻胚胎移植(FET)后出生的巨大儿(LGA)是否与冷冻技术或子宫内膜准备方案有关?
人工周期与更高的 LGA 风险相关,两种冷冻技术(玻璃化与慢速冷冻)或胚胎阶段(卵裂期胚胎与囊胚)之间无差异率。
多项研究比较了新鲜胚胎移植(ET)和 FET 的新生儿结局,并表明与新鲜 ET 相比,FET 与改善的新生儿结局相关,包括降低早产、低出生体重和小于胎龄儿(SGA)的风险。然而,这些研究也显示 FET 后 LGA 的风险增加。这种风险增加的潜在病理生理学尚不清楚;父母不孕、实验室程序(包括胚胎培养条件和冷冻-解冻过程)和子宫内膜准备治疗可能参与其中。
研究设计、大小、持续时间:通过对 2014 年至 2018 年法国 IVF 国家注册的前瞻性收集的新鲜 ET 或 FET 的单个分娩的标准化个体临床记录进行回顾性分析,进行了一项多中心流行病学数据研究。在生育中心进行了新鲜 ET 或 FET 的前瞻性收集。从参与的生育中心收集了补充数据,包括玻璃化介质和设备以及子宫内膜准备方案。
参与者/材料、设置、方法:数据来自 35 个法国 ART 中心,共纳入了 72789 例新鲜 ET、10602 例慢速冷冻 FET 和 39062 例玻璃化 FET。主要临床结局根据转移胚胎的来源(新鲜、慢速冷冻或玻璃化胚胎)和 FET 的子宫内膜准备(排卵或人工周期)进行呈现,比较了五个不同的组(新鲜、慢速冷冻-排卵周期、慢速冷冻-人工周期、玻璃化-排卵周期和玻璃化-人工周期)。活产单胎的胎儿生长障碍根据胎龄和性别特异性体重百分位数分布定义为 SGA 和 LGA,如果<10 百分位和≥90 百分位。使用具有 ART 中心作为随机效应的线性混合模型进行分析。
分别有 19006、1798 和 9195 例分娩对应于新鲜 ET、慢速冷冻 FET 和玻璃化 FET 的转移率分别为 26.1%、17.0%和 23.5%。FET 周期在排卵周期(n=21704)或人工周期(n=34237)中进行,导致 5910 和 10322 例妊娠,相应的转移妊娠率分别为 31.6%和 33.3%。与排卵周期相比,人工周期的自发流产率显著更高(33.3%比 21.4%,P<0.001,在慢速冷冻组和 31.6%比 21.8%,P<0.001,在玻璃化组)。因此,与排卵周期相比,人工周期的转移分娩率更低,无论是慢速冷冻还是玻璃化组(15.5%比 18.9%,P<0.001 和 22.8%比 24.9%,P<0.001)。在总共 26585 例活产单胎中,16413 例婴儿来自新鲜 ET,1644 例来自慢速冷冻 FET,8528 例来自玻璃化 FET。与新鲜 ET 组相比,FET 组的出生体重明显更高,两种冷冻技术之间无差异。同样,与新鲜 ET 组相比,FET 组的 LGA 发生率更高,SGA 发生率更低,无论使用哪种胚胎冷冻方法。在多变量分析中,与排卵周期相比,FET 后 LGA 的风险在人工周期中显著增加。相比之下,冷冻程序(玻璃化与慢速冷冻)或胚胎阶段(卵裂期胚胎与囊胚)与 LGA 风险无关。关于玻璃化方法,LGA 的风险与使用的玻璃化介质或胚胎阶段无关。
局限性、谨慎的原因:法国国家数据库中没有关于母体情况的数据,如孕次、BMI、不孕原因或母体合并症。特别是,我们不能排除 FET 后人工周期中观察到的 LGA 风险增加可能至少部分与一些母体因素的混杂效应有关。没有关于胚胎培养和孵育条件的信息。大多数玻璃化技术使用相同的设备和两种主要的玻璃化介质进行,限制了根据设备或玻璃化介质比较 LGA 风险的有效性。
我们的结果似乎令人放心,因为与慢速冷冻相比,胚胎玻璃化后没有观察到潜在的胎儿生长障碍。即使涉及其他因素,子宫内膜准备治疗似乎对 FET 后 LGA 风险的影响最大。FET 在排卵周期期间进行可以最大限度地降低胎儿生长障碍的风险。
研究资金/利益冲突:这项工作得到了法国生物医学局(资助号:19AMP002)的资助。作者均无任何利益冲突。
无。